semaglutide for alcohol GLP-1 Drug Substantially Reduced Heavy Consumption and Weight in Patients with Alcohol Use Disorder and Obesity KRVN 880 – KRVN 93.1

3163) was created in December 2025 for claims that Ozempic use caused NAION (an eye stroke that can cause vision loss)

If you want to see how TrimRx addresses donation eligibility more directly, our post on donating plasma on GLP-1 medications covers the same topic from a broader perspective

Tirzepatide (Eli Lilly): Same guidance

FDA officials said the agency saw the benefits of keeping acetaminophen widely available as outweighing the relatively rare risk of liver damage or death

Landmark trials show semaglutide (Wegovy) produces 10-15% body weight reduction over 68 weeks, while tirzepatide achieves 20-22% reduction by targeting dual GLP-1 and GIP pathways

In the case of semaglutide, it mimics a hormone that regulates your appetite and insulin secretion